Florida suboxone maintenance treatment is a form of Medication Assisted Treatment (MAT). Furthermore, MAT combines cognitive-behavioral therapies and medications to aid in the treatment of patients suffering from substance abuse. To illustrate, studies have shown that people who go through opioid detoxification and treatment without the aid of suboxone maintenance treatment drugs suffer a higher incidence of relapse. As a result, our Florida addiction treatment center staff devise plans that include suboxone maintenance treatment, which are designed to stabilize the drug-addicted person. Generally, clients removed from withdrawal are more receptive to further treatment, therapy and recovery.
Florida suboxone maintenance treatment has shown to be an effective tool for some clients to fight addiction. At the same time, It can save lives from overdose due to unknown additives in the heroin. Generally, street supplies of heroin contain fentanyl and other dangerous substances.
Medication Assisted Treatment (MAT) is certainly not a “cure” for addiction and is not appropriate for all clients. As such, the extent to which any doctor can help a client with substance abuse is limited by the medications which are currently approved by the FDA. Namely, Suboxone, Naltrexone and Vivitrol products are what our physicians have to work with in saving lives. Likewise, we always address a client’s individual circumstances, which requires a complete assessment by our highly trained and experienced physician. At this point, they can then properly administer Florida suboxone maintenance treatment, as appropriate. Also, an eligible client must participate in a full addiction treatment program that includes individual and group therapy with our licensed therapists.
Medication assisted treatment (MAT) can decrease cravings and relieve withdrawal symptoms. In particular, it will help you remain in Florida drug rehab and gain control over your opioid addiction without the distraction of cravings and fear of withdrawal.At the same time, we know that the longer clients stay in treatment, they will recover at higher rates than those that don't. In other words, medication assisted treatment (MAT) has created a new bridge to long-term sobriety.
Suboxone has been studied extensively since 1978, when it was first proposed for the treatment of opiate addiction. In fact, its the number recommendation by the The American Medical Association to combat opioid addiction. In addition, the AMA has presented that buprenorphine (generic ingredient in Suboxone) is effective for: